LAMISIL 250 (Lamisil 250 mg)
Generic Name: terbinafine
Pill with imprint LAMISIL 250 is White, Round and has been identified as Lamisil 250 mg. It is supplied by Novartis Pharmaceuticals.
Lamisil is used in the treatment of onychomycosis, toenail; cutaneous candidiasis; tinea capitis; onychomycosis, fingernail; tinea corporis and belongs to the drug class miscellaneous antifungals. There is no proven risk in humans during pregnancy. Lamisil 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for LAMISIL 250
Lamisil
- Generic Name
- terbinafine
- Imprint
- LAMISIL 250
- Strength
- 250 mg
- Color
- White
- Size
- 11.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Miscellaneous antifungals
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Novartis Pharmaceuticals
- Inactive Ingredients
-
silicon dioxide, hypromelloses, magnesium stearate, microcrystalline cellulose, sodium starch glycolate type A potato
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00078-0179 | Novartis Pharmaceuticals Corporation |
| 55289-0513 | PDRX Pharmaceuticals Inc. (repackager) |
| 54868-4008 | Physicians Total Care Inc. (repackager) |
| 49999-0466 | Lake Erie Medical and Surgical Supply (repackager) |
More about Lamisil (terbinafine)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- En Español
- 121 Reviews
- Generic Availability
- Drug class: miscellaneous antifungals
Consumer resources
Other brands: Terbinex
Professional resources
Other Formulations
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
